{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:08:13Z","timestamp":1765966093475,"version":"3.48.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.7759\/cureus.99438","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:00:36Z","timestamp":1765965636000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrated Boost vs. Sequential Scheme in Volumetric Modulated Arc Therapy (VMAT) for Trimodal Bladder Cancer Therapy: A Comparative Study"],"prefix":"10.7759","author":[{"given":"Reyzane","family":"El Mjabber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Alami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimaezzahra","family":"Aouzah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wissam","family":"Bezzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Dahbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadila","family":"Kouhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Ismaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa","family":"El Majjaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Naim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.02.038","article-title":"Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","volume":"66","author":"Ploussard G","year":"2014","unstructured":"Ploussard G, Daneshmand S, Efstathiou JA, et al.. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol. 2014, 66:120-37. 10.1016\/j.eururo.2014.02.038","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2025.06.3866","article-title":"Health-related quality of life in patients treated for nonmetastatic muscle-invasive bladder cancer: radical cystectomy versus bladder-preserving therapy","volume":"123","author":"Br\u00fcck K","year":"2025","unstructured":"Br\u00fcck K, Atema V, Leliveld AM, et al.. Health-related quality of life in patients treated for nonmetastatic muscle-invasive bladder cancer: radical cystectomy versus bladder-preserving therapy. Int J Radiat Oncol Biol Phys. 2025, 123:1004-17. 10.1016\/j.ijrobp.2025.06.3866","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-111","article-title":"A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer","volume":"7","author":"Foroudi F","year":"2012","unstructured":"Foroudi F, Wilson L, Bressel M, et al.. A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer. Radiat Oncol. 2012, 7:111. 10.1186\/1748-717X-7-111","journal-title":"Radiat Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.5548","article-title":"Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233","volume":"32","author":"Mak RH","year":"2014","unstructured":"Mak RH, Hunt D, Shipley WU, et al.. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol. 2014, 32:3801-9. 10.1200\/JCO.2014.57.5548","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al.. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017, 67:93-9. 10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"ref6","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-55.","journal-title":"Am J Clin Oncol"},{"key":"ref7","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). (2017). https.\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2003.05.001","article-title":"A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy","volume":"69","author":"Roeske JC","year":"2003","unstructured":"Roeske JC, Bonta D, Mell LK, Lujan AE, Mundt AJ. A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy. Radiother Oncol. 2003, 69:201-7. 10.1016\/j.radonc.2003.05.001","journal-title":"Radiother Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(01)01804-1","article-title":"The position and volume of the small bowel during adjuvant radiation therapy for rectal cancer","volume":"51","author":"Nuyttens JJ","year":"2001","unstructured":"Nuyttens JJ, Robertson JM, Yan D, Martinez A. The position and volume of the small bowel during adjuvant radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2001, 51:1271-80. 10.1016\/s0360-3016(01)01804-1","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(03)01569-4","article-title":"Assessment of different IMRT boost delivery methods on target coverage and normal\u2011tissue sparing","volume":"57","author":"Dogan N","year":"2003","unstructured":"Dogan N, King S, Emami B, et al.. Assessment of different IMRT boost delivery methods on target coverage and normal\u2011tissue sparing. Int J Radiat Oncol Biol Phys. 2003, 57:1480-91. 10.1016\/s0360-3016(03)01569-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"Delineation of organs at risk and dose constraints [Article in French]","volume":"20 Suppl","author":"No\u00ebl G","year":"2016","unstructured":"No\u00ebl G, Antoni D, Barillot I, Chauvet B. Delineation of organs at risk and dose constraints [Article in French]. Cancer Radiother. 2016, 20 Suppl:S36-60. 10.1016\/j.canrad.2016.07.032","journal-title":"Cancer Radiother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.027","article-title":"Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results","volume":"20","author":"R\u00f6del C","year":"2002","unstructured":"R\u00f6del C, Grabenbauer GG, K\u00fchn R, et al.. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol. 2002, 20:3061-71. 10.1200\/JCO.2002.11.027","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.09.036","article-title":"Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy","volume":"73","author":"Kaufman DS","year":"2009","unstructured":"Kaufman DS, Winter KA, Shipley WU, et al.. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy. Urology. 2009, 73:833-7. 10.1016\/j.urology.2008.09.036","journal-title":"Urology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1022","article-title":"Bladder preservation by combined modality therapy for invasive bladder cancer","volume":"15","author":"Kachnic LA","year":"1997","unstructured":"Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, Shipley WU. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol. 1997, 15:1022-9. 10.1200\/JCO.1997.15.3.1022","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James ND","year":"2012","unstructured":"James ND, Hussain SA, Hall E, et al.. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 2012, 366:1477-88. 10.1056\/NEJMoa1106106","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70255-9","article-title":"Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial","volume":"14","author":"Mitin T","year":"2013","unstructured":"Mitin T, Hunt D, Shipley WU, et al.. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial. Lancet Oncol. 2013, 14:863-72. 10.1016\/S1470-2045(13)70255-9","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90306-g","article-title":"Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12","volume":"25","author":"Tester W","year":"1993","unstructured":"Tester W, Porter A, Asbell S, et al.. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys. 1993, 25:783-90. 10.1016\/0360-3016(93)90306-g","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(03)00718-1","article-title":"RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy","volume":"57","author":"Hagan MP","year":"2003","unstructured":"Hagan MP, Winter KA, Kaufman DS, et al.. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys. 2003, 57:665-72. 10.1016\/s0360-3016(03)00718-1","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.11.010","article-title":"Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience","volume":"61","author":"Efstathiou JA","year":"2012","unstructured":"Efstathiou JA, Spiegel DY, Shipley WU, et al.. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012, 61:705-11. 10.1016\/j.eururo.2011.11.010","journal-title":"Eur Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.07.976","article-title":"Adaptive radiotherapy for invasive bladder cancer: a feasibility study","volume":"64","author":"Pos FJ","year":"2006","unstructured":"Pos FJ, Hulshof M, Lebesque J, Lotz H, van Tienhoven G, Moonen L, Remeijer P. Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int J Radiat Oncol Biol Phys. 2006, 64:862-8. 10.1016\/j.ijrobp.2005.07.976","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.12.003","article-title":"Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer","volume":"79","author":"Lalondrelle S","year":"2011","unstructured":"Lalondrelle S, Huddart R, Warren-Oseni K, et al.. Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys. 2011, 79:705-12. 10.1016\/j.ijrobp.2009.12.003","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444309-integrated-boost-vs-sequential-scheme-in-volumetric-modulated-arc-therapy-vmat-for-trimodal-bladder-cancer-therapy-a-comparative-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:00:45Z","timestamp":1765965645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444309-integrated-boost-vs-sequential-scheme-in-volumetric-modulated-arc-therapy-vmat-for-trimodal-bladder-cancer-therapy-a-comparative-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.99438","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}